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ABSTRACT
We have developed a simple method called I-Block
assay, which can detect sequence-specific binding
of proteins to DNA in Escherichia coli. The method
works by detecting competition between the protein
of interest and RNA polymerase for binding to over-
lapping target sites in a plasmid-borne lacI promoter
variant. The assay utilizes two plasmids and an E.
coli host strain, from which the gene of the Lac re-
pressor (lacI) has been deleted. One of the plasmids
carries the lacI gene with a unique NheI restriction
site created in the lacI promoter. The potential recog-
nition sequences of the tested protein are inserted
into the NheI site. Introduction of the plasmids into
the E. coliΔlacI host represses the constitutive -
galactosidase synthesis of the host bacterium. If the
studied protein expressed from a compatible plas-
mid binds to its target site in the lacI promoter, it will
interfere with lacI transcription and lead to increased
-galactosidase activity. The method was tested with
two zinc finger proteins, with the lambda phage cI857
repressor, and with CRISPR-dCas9 targeted to the
lacI promoter. The I-Block assay was shown to work
with standard liquid cultures, with cultures grown
in microplate and with colonies on X-gal indicator
plates.
INTRODUCTION
Sequence-specific DNA–protein interactions are at the core
of many biological processes (1). During characterization of
DNA binding proteins it is often important to test whether
the protein can bind to a particular DNA sequence and to
explore how alterations in the protein and/or in the DNA
affect the binding strength and/or specificity (for reviews
see (2–4)). There is a large variety of in vitro methods for
studying binding affinity and specificity of DNA-binding
proteins (5–15). A drawback of these methods is that they
either require purified proteins and/or are technically de-
manding.
There are Escherichia coli-based techniques suitable to
investigate sequence-specific DNA–protein interactions in
vivo without the need of protein purification. These one-
and two-hybrid methods were designed to determine the
binding site of a protein or to select protein variants show-
ing high affinity to a particular DNA sequence. The tech-
niques involve fusing the protein of interest to a subunit of
RNA polymerase and cloning the assumed binding site or
an oligonucleotide library potentially containing the bind-
ing site closely upstream of the promoter of a selectable re-
porter gene, so that binding of the chimeric protein to the
target site can enhance the transcription rate of the reporter
gene (16–23). Because of the need to construct protein fu-
sions, the one- and two-hybrid approaches are laborious.
In the course of our work with C2H2 zinc finger proteins,
we needed to test whether the proteins can bind to a spe-
cific DNA sequence in E. coli. Because the published E. coli-
based methods appeared unnecessarily complicated for an-
swering such relatively simple question, we decided to de-
velop a simpler technique, which would be able to detect
binding of a protein to its target site without the require-
ment of creating protein fusions. The assay reported here
is based on the well-characterized regulatory mechanism
of the E. coli lac operon and works by blocking transcrip-
tion of the Lac repressor gene (lacI) resulting in elevated -
galactosidase activity. We describe construction of the assay
and show its application with two zinc finger proteins, with
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the catalytically inactive dCas9 variant of the Cas9 protein
and with the temperature-sensitive cI857  phage repres-
sor. We demonstrate application of the technique with cells
grown in liquid cultures and with colonies grown on the sur-
face of X-gal indicator plates. With reference to its mecha-
nism of blocking production of the LacI repressor protein,
we suggest to call the method I-Block assay.
MATERIALS AND METHODS
Bacterial strains and growth conditions
Escherichia coli DH10B (F− endA1 recA1 galE15 galK16
nupG rpsL ΔlacX74 80dlacZΔM15 araD139 Δ(ara
leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC) relA1 spoT1
−) (24) was used as general cloning host. The E. coli
strain CJ236 FΔ(HindIII)::cat (Tra+ Pil+ CamR)/
ung-1 relA1 dut-1 thi-1 spoT1 mcrA, was used to generate
uracil-containing single-stranded DNA for site-directed
mutagenesis (25). The E. coli ER1821ΔlacI strain was con-
structed in this work from ER1821 F- glnV44 e14-(McrA-)
rfbD1? relA1? endA1 spoT1?thi-1 Δ(mcrC-mrr)114::IS10
(26) by deleting the chromosomal lacI gene using the
method described in (27).
Bacteria were grown in LB liquid medium (28) in screw-
cap flasks, in test tubes or in wells of microtiter plates at
30◦C. Expression of zinc-finger proteins was induced by
adding 0.1% L-arabinose (Sigma) to the medium. Ampi-
cillin (Ap), kanamycin (Kn) and chloramphenicol (Cm)
were used at 100, 50 and 25 g/ml concentration, respec-
tively. Colonies producing -galactosidase were screened on
LB agar plates containing reduced concentration of yeast
extract (2.5 g per liter) and 40 g/ml 5-bromo-4-chloro-3-
indolyl -D-galactoside (X-gal).
Plasmids
Plasmids are listed in Supplementary Table S1. The plas-
mids pOK12 (29), pACYC184 (30), pUA66 (KnR) (31) and
pBAD24 (ApR) (32) were used as cloning vectors. Construc-
tion of plasmids is described in Supplementary Data (Sup-
plementary Figure S1).
The pLacI plasmids expressing the Lac repressor were
named to indicate the vector (pOK-, pAC-, pUA- or pdUA-
), the lacI promoter variant, the cloning site(s) created in
the lacI promoter region and (in parentheses) the site of in-
sertion with the inserted target sequence of the tested pro-
tein. The PvuI, NheI, MunI and EcoRI cloning sites are
denoted by the letter P, N, M and E, respectively. For exam-
ple, the plasmid pUA-lacIPN(N-6ZA) is based on the vector
pUA66, contains the lacI gene with engineered unique PvuI
and NheI sites in the lacI promoter, and carries the 6ZA zinc
finger protein binding site inserted into the NheI site.
The plasmids pB6ZA and pB6ZB contain the genes of
the 6ZA or the 6ZB zinc finger proteins (original names:
6-ZFP-A and 6-ZFP-B (33)) cloned in pBAD24. Plas-
mid pcI857, a derivative of pORTMAGE-2 (34) consti-
tutively expresses the temperature-sensitive cI857 mutant
of the lambda phage repressor. Plasmid pdCas9, a gift
from Luciano Marraffini (Addgene plasmid # 46569; http:
//n2t.net/addgene:46569; RRID:Addgene 46569) encodes
the catalytically inactive D10A, H840A double mutant
of the Cas9 nuclease, expresses the tracrRNA and car-
ries a minimal CRISPR array with BsaI sites for insertion
of oligonucleotide duplexes defining the target sequence
(35). The plasmids pdCas9-376, pdCas9-385, pdCas9-458,
pdCas9-516, pdCas9-518 and pdCas9-520 were constructed
by cloning the double-stranded oligonucleotides AK376-
377, AK385-386, AK458-459, AK516-517, AK518-519 and
AK520-521, respectively (Supplementary Table S2) be-
tween the BsaI sites of pdCas9. The numbers added as ex-
tensions in the names of the pdCas9- plasmids indicate the
oligonucleotides corresponding to the top strand of the tar-
geted sequence (Figure 2, Supplementary Tables S1 and 2).
-galactosidase assay
To determine -galactosidase activity, cells were grown in
the presence or absence of arabinose overnight or for 4–
8 h at 30◦C. Cells were permeabilized and -galactosidase
activity was measured by the original (36) or by a simpli-
fied version (37) of the Miller protocol. In cells grown in
microplate wells -galactosidase activity was determined in
Synergy™ HT or Synergy 2 Multi-Mode Microplate Read-
ers (Bio-Tek). Details are described in Supplementary Data.
Colonies producing -galactosidase were identified on X-
gal containing agar plates (28,36).
Other methods
Cloning of DNA fragments was done by standard methods
(28). Enzymes were purchased from Thermo Scientific or
New England Biolabs. Site-directed mutagenesis was per-
formed either by the Kunkel method (25) or by a variant
of the QuikChange method as described in Supplementary
Data. Conditions of measuring expression of the reporter
green fluorescent protein fused to lacI promoter variants are
described in Supplementary Data. Deoxyoligonucleotides
were synthesized in the Nucleic Acid Synthesis Laboratory
of this institute and are listed in Supplementary Table S2.
All other chemicals were analytical grade commercial prod-
ucts. Bar diagrams were created and statistical analysis was
performed with the GraphPad Prism program (GraphPad
Software, Inc.).
RESULTS
Principle of the assay
The assay is based on the regulatory mechanism of the E.
coli lac operon. In the wild-type arrangement the lacI gene
encoding the Lac repressor is located on the bacterial chro-
mosome very closely to the lac operon and is transcribed
from the weak constitutive promoter PlacI. In the absence
of inducer the Lac repressor binds to the lac operator and
shuts off transcription of the lacZYA genes (38,39).
We envisaged a technique, which would detect binding
of a protein to DNA by interference with transcription
of the E. coli lacI gene resulting in the induction of -
galactosidase synthesis. The scheme of the assay is shown
in Figure 1. An E. coli host from which the chromosomal
copy of the lacI gene had been deleted contains two com-
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Figure 1. Principle of the I-Block assay. An Escherichia coli host strain from which the chromosomal copy of the lacI gene has been deleted, carries two
compatible plasmids (generic names pLacI and pDBP). The plasmid pLacI encodes the Lac repressor (LacI), whereas pDBP carries the gene of the protein
of interest (DNA Binding Protein, DBP). The assumed binding site of the tested DBP is inserted into the promoter of the lacI gene. (A) In the absence of
DBP the lacI gene on pLacI is transcribed, and the synthesized Lac repressor blocks transcription of the chromosomal lacZ gene. (B) When the DBP is
synthesized, it binds to its cognate site in the lacI promoter and interferes with lacI transcription leading to production of -galactosidase.
expresses the E. coli Lac repressor, whereas the other plas-
mid (generic name: pDBP) expresses the DNA Binding Pro-
tein (DBP) of interest. Nucleotide sequence of the 5′-end
of the wild-type lacI gene is shown in Figure 2. The as-
sumed recognition sequence of the DNA binding protein
is inserted into the lacI promoter in a position, where it
does not severely impair lacI transcription. We expected
that constitutive -galactosidase synthesis of the lacI dele-
tion host strain would be repressed by the Lac repressor syn-
thesized from pLacI, but binding of the tested protein to
its target site on pLacI would interfere with lacI transcrip-
tion and lead to induction of -galactosidase production
(Figure 1).
Construction of the assay system and pilot experiments
The LacI-deficient E. coli host bacterium was created by
deleting the lacI gene from E. coli ER1821. The 1189 bp
deletion removed the genomic segment between coordinates
366349–367537 of E. coli MG1655. The deletion strain E.
coli ER1821ΔlacI produces -galactosidase constitutively.
Conditions of the assay were first tested with two C2H2
zinc finger proteins (6-ZFP-A and 6-ZFP-B) whose bind-
ing specificity was known from in vitro experiments. The
6-ZFP-A protein recognizes the sequence 5′-GCC-GGG-
GCT-GGG-GGA-GGG, whereas 6-ZFP-B recognizes 5′-
GGA-GTT-GGG-GGA-GTG-AGT (33). In this paper, for
brevity, 6-ZFP-A and 6-ZFP-B will be named 6ZA and
6ZB, respectively. To express the two zinc finger proteins
in inducible fashion, the 6ZA and 6ZB genes were cloned
in the expression vector pBAD24 to obtain pB6ZA and
pB6ZB, respectively. In these plasmids transcription of the
6ZA and 6ZB genes is controlled by the araBAD promoter
and can be induced with arabinose.
Details of constructing and testing the different pLacI
plasmids are described in Supplementary Data. The first
pLacI versions were based on the medium copy number
vectors pOK12 (29) and pACYC184 (30), contained the
strong lacIQ promoter (40–42) and had a MunI cloning
site created in the 5′-untranslated region between the lacI Q
promoter and the GTG start codon (Figure 2). When the
plasmids pAC-lacIQM-(M-6ZA) or pAC-lacIQM-(M-6ZB)
[i.e. pAC-lacIQM containing the 6ZA or the 6ZB binding
site inserted into the MunI site; for plasmid nomenclature
see ‘Materials and Methods’ section] were introduced into
E. coli ER1821ΔlacI, the high -galactosidase activity of
the host was repressed, but the expected increase of -
galactosidase activity upon induction of the synthesis of the
cognate zinc finger protein was not observed. We hypothe-
sized that the failure to detect binding by the two zinc finger
proteins had two possible reasons. One of the possibilities
was that the multiple plasmid-borne copies of the lacIQ gene
and the elevated transcription rate characterizing the lacIQ
promoter (40–42) resulted in Lac repressor concentrations,
which were too high for achieving even partial induction
of the lac operon. The second possibility was that proteins
bound to the 5′-untranslated region cannot efficiently block
the transcribing RNA polymerase.
To find the right conditions for the assay, several pLacI
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Figure 2. Nucleotide sequence of the Escherichia coli lacI promoter region (41,44–45). The −35 and −10 motifs are highlighted in gray, the transcriptional
start site in red and the GTG start codon in green. The PvuI, NheI, MunI and EcoRI sites created by site directed mutagenesis are shown above the
sequence. The mutated nucleotides are underlined. The AK376, AK385, AK458, AK516, AK518 and AK520 oligonucleotides shown above the sequence
define target sites for CRISPR-dCas9.
of the plasmids was guided by two goals: lowering the con-
centration of the Lac repressor and finding a site within the
lacI promoter, where binding proteins can efficiently inter-
fere with lacI transcription. The pACYC184 vector was re-
placed with the pSC101-based low copy number plasmid
vector pUA66 (31) and the strong lacIQ promoter with the
weaker (41) wild-type lacI promoter. Two unique restriction
sites (PvuI and NheI) were created in the wild-type lacI pro-
moter by site-directed mutagenesis. The PvuI site is located
a few bp upstream of the −35 conserved motif, whereas the
NheI site partially overlaps the −10 conserved element. Cre-
ation of the NheI site introduced an A to C change in the
conserved −10 element (Figure 2). The lacI gene variants
carrying the MunI, PvuI or the NheI site were designated
lacIM, lacIP and lacIN, respectively. The changes described
above led to partial success. The pUA66-based plasmids
pUA-lacIN-(N-6ZA) and pUA-lacIPN-(N-6ZA) containing
the 6ZA target sequence inserted into the NheI cloning site
repressed, and expression of the 6ZA protein restored 50–
60% of the original -galactosidase activity (Supplemen-
tary Data and Figure S2C and E). However, expression of
the 6ZB protein in the cell containing the cognate pUA-
lacIN-(N-6ZB) plasmid did not increase -galactosidase ac-
tivity (not shown).
The assay system was also tested with the non-zinc finger
DNA binding protein dCas9. Targeting the constitutively
expressed dCas9 to the sequence between positions −41 and
−22 (AK385, Figure 2) did not induce -galactosidase pro-
duction (Supplementary Figure S3A–E), whereas targeting
to the sequence between positions +1 to + 20 (AK376, Fig-
ure 2) led to a significant increase of -galactosidase activ-
ity, but only when the lacI promoter contained the NheI
site (Supplementary Figure S3I and J). Because in the ex-
periments with dCas9 no foreign sequence was in the NheI
site, we concluded that the ability to induce -galactosidase
synthesis with the lacIN and lacIPN variants (Supplementary
Figure S3I and J) was due to the A to C mutation associ-
ated with the creation of the NheI site in the lacI promoter
(Figure 2). A possible explanation was that the mutation
weakened the lacI promoter and lowered the Lac repressor
concentration to a range, where the competing effect of the
6ZA and dCas9 proteins became detectable. A comparison
of the promoters fused to the green fluorescent protein (gfp)
reporter gene showed that the lacIN promoter was indeed
weaker than the wild-type lacI promoter (Supplementary
Figure S4).
Use of the binding assay with standard liquid cultures, mi-
crotiter plates and colonies
The data described above identified two essential conditions
for the functional assay: low copy number pLacI plasmid
and the weak lacIN promoter. Moreover, the results of the
initial experiments suggested that the NheI site overlapping
the −10 element could be suitable for inserting the tested
target sequences.
Because efficient interference with lacIN transcription
was also observed with dCas9 targeted to the first twenty
transcribed nucleotides (Supplementary Figure S3I and J),
and insertion of different foreign (target) sequences into the
5′-untranslated region was thought to cause less variation
in the expression of the lacIN gene than insertion of these
sequences immediately downstream of the conserved −10
element, we assumed that the MunI site could be better for
the assay than the NheI site. Use of the MunI site in com-
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weak lacIN promoter could not be tested because pUA66
contained three MunI sites, which made the use of MunI
as cloning enzyme impractical. To obtain a pUA66-based
pLacI plasmid with a unique cloning site in the lacI 5′-
untranslated region, an EcoRI site was created at the po-
sition exactly corresponding to the MunI site (Figure 2).
To optimize the assay conditions, a family of pLacI plas-
mids containing different combinations of the PvuI, NheI
and EcoRI cloning sites with the inserted 6ZA and/or 6ZB
binding sites were created as described in Supplementary
Data. The vector part of these plasmids (denoted by the pre-
fix pdUA-) slightly differed from pUA66 in that it carried a
deletion removing the gene of the green fluorescent protein
and an EcoRI site originally present in pUA66. These plas-
mids were used in the rest of the work.
To simplify the assay and to make it more reliable, two
changes were introduced. In the experiments described
above addition of the inducer (and carbon source) ara-
binose increased the growth rate and led to substantially
higher cell densities than those of the uninduced cultures
making comparison of -galactosidase activities difficult.
To maintain comparable growth rates, uninduced cultures
were supplemented with 0.1% glucose at the same time
when arabinose was added to the induced cultures. An-
other difference compared to previous experiments was that
the traditional Miller protocol, which uses chloroform and
sodium dodecyl sulfate for permeabilization of the cells be-
fore measuring -galactosidase activity (36), was replaced
with a simpler method employing hexadecyltrimethylam-
monium bromide (CTAB) and sodium deoxycholate for
permeabilization (37).
Measurements carried out under the new conditions con-
firmed previous results (Supplementary Figure S2C and
E) with pUA-lacIN carrying the 6ZA binding sequence in
the NheI site, but could also demonstrate binding of the
6ZB zinc finger protein (Figure 3A–D), which was not de-
tectable under the conditions of the classical Miller assay
(see above). In general, in our hands the simplified ver-
sion of the Miller assay (37) gave more reproducible re-
sults than the original protocol (36). The observed differ-
ence between the -galactosidase activities elicited by 6ZA
and 6ZB presumably indicates the difference between the
binding strengths of the two zinc finger proteins to their re-
spective target sites. Induction of -galactosidase synthesis
by 6ZA binding occurred only with the cognate target site
[pdUA-lacIN-(N-6ZA)], and no increase of -galactosidase
activity was observed with pdUA-lacIN(N-6ZB), which car-
ried the 6ZB recognition sequence (Figure 3E) showing that
the protein–DNA interaction detected by the assay was
sequence-specific.
The new conditions of the binding assay were validated
with dCas9 and with the temperature-sensitive cI857 mu-
tant of the  phage repressor. Confirming previous results
(Supplementary Figure S3I and J) obtained with the orig-
inal Miller method, targeting dCas9 to the 5′-untranslated
region of the lacIN gene containing the NheI site in the −10
element of the promoter resulted in high -galactosidase ac-
tivity (Figure 3F and Supplementary Figure S5). In cells
carrying the OR1 and OR2 lambda phage operator in-
serted into the NheI site of pdUA-lacIN expression of the
temperature-sensitive cI857 repressor resulted in increased
-galactosidase activity at the permissive temperature 30◦C,
but not at 42◦C (Figure 3G).
With the goal to adapt the assay to processing multi-
ple samples, cultures were grown and assayed in microplate
wells of a BioTek Synergy instrument as described in Sup-
plementary Data. The ability to grow several samples in
parallel allowed easy comparison of different pdUA-lacI-
based plasmids containing the 6ZA or the 6ZB recognition
sequence inserted in the PvuI, NheI or the EcoRI site. In
accordance with previous results, the assay worked only in
cases when the recognition sequence of the tested protein
was in the NheI site, and did not work when it was in the
PvuI or in the EcoRI site (Figure 4). Plasmid combina-
tions, which were tested in cultures grown in flasks (Figure
3) as well as in microplates (Figure 4), showed similar -
galactosidase activities.
Plasmids with the engineered PvuI and EcoRI cloning
sites and with the 6ZA recognition sequence inserted in the
EcoRI site showed a phenotype that differed from that of
all other pdUA-lacI plasmids tested: pdUA-lacIPE(E-6ZA)
repressed -galactosidase synthesis of the host bacterium
only partially, and pdUA-lacIPNE(E-6ZA) did not repress it
at all (Figure 4) suggesting that the combined effect of the
changes introduced with the PvuI, NheI sites and with the
6ZA sequence was a substantial decrease of the lacI tran-
scription rate. The detrimental effect of the mutations as-
sociated with the PvuI and NheI sites is not surprising be-
cause of their position relative to the conserved elements of
the lacI promoter. The mechanism of the effect of the 6ZA
target site inserted into the nonconserved sequence of the
first transcribed nucleotides is less clear, a possible expla-
nation can be that it inhibits promoter escape by the RNA
polymerase (43).
For many applications screening a large number of clones
is essential. To test whether the method described above can
be used to screen colonies on solid medium, ER1821ΔlacI
cells harboring either pdUA-lacIN(N-6ZA) plus pB6ZA or
pdUA-lacIN(N-6ZB) plus pB6ZA were spread on the sur-
face of LB/Ap/Kn/arabinose/X-gal agar plates and incu-
bated overnight at 37◦C. Colonies containing the pdUA-
lacIN plasmid with the 6ZA recognition sequence in the
NheI site turned blue, whereas those with the 6ZB recog-
nition site remained white (Figures 5 and Supplementary
Figure S6).
DISCUSSION
In this work we have converted the E. coli lac operon into
a new genetic circuit suitable to test whether a protein can
bind to a particular DNA sequence. The technique utilizes
the regulatory mechanism of the lac operon and works by
detecting competition between the studied protein and E.
coli RNA polymerase for binding to overlapping target sites
in the plasmid-borne lacIN promoter (Figure 1). With ref-
erence to its working mechanism we suggest to call the
method I-Block assay. The method was tested with two zinc
finger proteins recognizing 18 bp sequences, with CRISPR-
dCas9 targeted to the lacI promoter and with the cI857
temperature-sensitive  phage repressor.
Establishment of the method turned out to be more dif-
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Figure 3. Detection of sequence-specific DNA–protein binding in Escherichia coli by the I-Block assay using samples of standard liquid cultures. The E.
coli ER1821ΔlacI host contained the indicated plasmids. -galactosidase activities were determined from overnight cultures using the simplified Miller
assay and are the average of three independent experiments. Error bars indicate standard error of the mean values (for clarity only above the bars). The
pdUA- plasmids carry the lacI gene with PvuI, NheI or EcoRI acceptor site(s) engineered in the lacI promoter region (see Figure 2). The presence of the
PvuI, NheI or EcoRI acceptor sites is indicated by the letters P, N and E, respectively in lower index. (A–E) In the names of the plasmids the extensions
in parentheses indicate the presence of the 6ZA or 6ZB binding site cloned in the NheI acceptor site. The plasmids pB6ZA and pB6ZB express, upon
arabinose induction, the 6ZA and the 6ZB zinc finger protein, respectively. ara, arabinose; glu, glucose added to the culture. (F) The pdCas9-AK518
plasmid constitutively expresses the dCas9 protein and the guide RNA determining the dCas9 binding site (AK518, Figure 2). (G) OR,  phage OR1
and OR2 operator cloned in the NheI acceptor site. The pcI857 plasmid constitutively expresses the temperature-sensitive  cI857 repressor. The schemes
above the graphs show the lacI promoter variants with the approximate position of the 6ZA, 6ZB, dCas9 or  repressor binding sites. P values derived
from one-way ANOVA and subsequent Tukey’s multiple comparison tests are shown in Supplementary Data.
Data). Three conditions, the right concentration of the Lac
repressor, the position of the inserted target site and the sim-
plified method of measuring -galactosidase activity proved
crucial for the functional assay. The optimal Lac repressor
concentration was found to be dependent on three factors
(low copy number pLacI plasmid, wild-type lacI gene in-
stead of lacIQ and a mutation in the conserved −10 element
of the lacI promoter). The relatively low LacI concentration
determined by these conditions was sufficiently high for effi-
cient repression of -galactosidase synthesis in the absence
of a tested DNA binding protein, but suitably low to allow
detection of small changes in the rate of lacI transcription
as a result of the tested protein’s interference.
At the beginning of the work we assumed that binding of
a protein between the promoter and the start codon of the
lacI gene would efficiently block lacI transcription, thus the
5′-untranslated region would be suitable for inserting the
target sites of the tested proteins. However, when the tar-
get site was inserted into the MunI or into the EcoRI site
located in the 5′-untranslated sequence, binding of the two
zinc finger proteins had no detectable effect on lacI tran-
scription. Similarly, the PvuI site located a few bp upstream
of the −35 element, proved unsuitable as acceptor site for
target sequences. Zinc finger protein binding was only de-
tectable in cases when the target sequence was inserted into
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Figure 4. (A–C) Detection of sequence-specific DNA–protein binding by
the I-Block assay using cultures grown in wells of microtiter plates. The Es-
cherichia coli ER1821ΔlacI host contained the indicated pdUA-lacI-based
plasmids. For nomenclature of the plasmids and for experimental condi-
tions see the legend of Figure 3. Empty bars, no plasmid, culture grown
in the presence of arabinose; striped bars, pdUA-lacI variant, grown in
the presence of arabinose; gray bars, pdUA-lacI variant plus the plasmid
(pB6ZA or pB6ZB) expressing the cognate zinc finger protein, grown in
the presence of glucose; black bars, pdUA-lacI variant plus the plasmid
(pB6ZA or pB6ZB) expressing the cognate zinc finger protein, grown in
the presence of arabinose. P-values derived from one-way ANOVA and
subsequent Tukey’s multiple comparison tests are shown in Supplemen-
tary Data.
Figure 5. Detection of sequence-specific DNA–protein binding by the I-
Block assay in colonies grown on X-gal indicator plates. Cells of Es-
cherichia coli ER1821ΔlacI harboring pdUA-lacIN(N-6ZA) + pB6ZA or
pdUA-lacIN(N-6ZB) + pB6ZA were mixed in 4 to 1 ratio, and plated on the
surface of X-Gal plates containing arabinose to induce expression of the
6ZA zinc finger protein. White arrows indicate colonies containing plas-
mids with the non-cognate 6ZB binding site, whereas blue arrows indicate
colonies containing plasmids with the cognate 6ZA target site.
−10 conserved element. An important message of our data
is that in E. coli a DNA-binding protein can more efficiently
interfere with transcription by competing with binding of
RNA polymerase to the promoter than by obstructing the
elongating enzyme.
Creation of the NheI site, which meant an A to C change
in the −10 element, turned out to have two-fold advantage
for the assay. Firstly, it created an acceptor site at a position,
where a protein can efficiently interfere with RNA poly-
merase binding to the lacI promoter. The second effect of
the A to C mutation was that the assay system became sen-
sitive to subtle changes in lacI transcription. The NheI site
overlaps with the −10 box only partially, thus cloning of for-
eign sequences into the NheI site does not lead to changes in
the conserved elements of the lacIN promoter, which makes
comparison of different target sites more reliable. Of the
pLacI plasmid variants tested, pdUA-lacIN appears to be
the best for the assay.
The I-Block assay was shown to work with standard liq-
uid cultures, with cells grown in microplate wells as well as
with colonies on X-gal indicator plates. A great advantage
of the method is simplicity, it only requires basic techniques
of molecular biology. In contrast to published approaches
designed to detect specific DNA–protein interactions in E.
coli (16–23), the I-Block assay does not require construction
of protein fusions, which makes it easier to use and avoids
potential influence of the fusion partner on the structure
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We wish to develop the I-Block assay into a semi-
quantitative method suitable to estimate the DNA-binding
affinities of proteins in E. coli. One of the potential prob-
lems hindering quantitativity of the assay is the variability
inherent to the lacIN gene and the gene of the tested pro-
tein residing on different replicons. We have preliminary re-
sults showing that the method can work in an arrangement
where the two genes are on the same plasmid (Supplemen-
tary Figure S7). For quantitative data on binding strength,
it will be essential to measure the intracellular concentra-
tion of the studied protein, which can be, due to differences
in transcription, translation and protein stability, very dif-
ferent for different proteins. For the envisaged version of the
assay we plan to explore the possibilities of using fluorescent
tags fused to the studied protein.
Here we demonstrated that the I-Block assay can be used
to test whether a protein can bind to a particular DNA se-
quence in E. coli. We envisage application of the method for
comparing affinities of different proteins to the same DNA
sequence, or for comparing affinities of a protein to different
potential target sites. The I-Block assay, in its present form,
does not match the capacity of the powerful one-hybrid and
two-hybrid systems employing direct selection (16–23) to
determine the binding site of a protein or to find the best
binding protein variant from large sequence libraries, but
it can potentially be developed into a direct selection tech-
nique. In the envisaged high throughput version of the as-
say, to avoid using the carbon source arabinose, the stud-
ied protein would be expressed from a plasmid constitu-
tively. To find the target site of the studied protein, a library
of randomized oligonucleotides would be cloned into the
NheI site of pdUA-lacIN. Double transformants harboring
pdUA-lacIN with the inserted oligonucleotide library and
the plasmid constitutively expressing the protein of interest
would be spread on the surface of minimal agar plates con-
taining the non-inducing -galactosidase substrate phenyl-
-D-galactoside (P-Gal) as the only carbon source (36).
Under such conditions only cells producing -galactosidase
are expected to form colonies.
DNA-binding proteins differ widely in their binding
modes, and can have, for example, enthalpy-driven or
entropy-driven binding mechanism (for references see (1)).
Here we showed that the I-Block assay worked with pro-
teins representing three different classes of DNA-binding
proteins (zinc finger, Cas9 and lambda phage cI repressor),
which suggests that the technique will be generally applica-
ble.
The E. coli lac operon has been a source of inspiration
for concepts and countless techniques for 60 years. We be-
lieve that the I-Block assay described here will be a useful
addition to the -galactosidase based toolbox of molecular
biology.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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